JuxtaTalks: Cancer of Evidence-Based Medicine
“Positive findings are around twice as likely to be published as negative findings. This is a cancer at the core of evidence-based medicine.”
When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark.
In collaboration with JULS – Journal of Undergraduate Life Sciences and Education and Equity, We will be screening an impassioned TED talk, where Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous. Here is a link to the talk: http://www.ted.com/talks/ben_goldacre_what_doctors_don_t_know_about_the_drugs_they_prescribe.html
The screening will take place at 1:15pm, followed by an informal discussion about the role of journals and publications in ensuring that evidence is not distorted.
We have confirmed Dr. Nancy Olivieri’s attendance at our forum. Dr. Olivieri’s much-publicized case put the limits of academic freedom to the test, and raised important questions regarding conflicts of interest in research. Don’t miss this opportunity to have a conversation with one of the most controversial and renowned researchers of our time!
